The Advantages and Challenges of Using FDG PET/CT for Response Assessment in Melanoma in the Era of Targeted Agents and Immunotherapy
Crossref DOI link: https://doi.org/10.1007/s00259-017-3691-7
Published Online: 2017-04-07
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wong, Annie N. M.
McArthur, Grant A.
Hofman, Michael S.
Hicks, Rodney J.
Funding for this research was provided by:
National Health and Medical Research Council (APP1108050, APP1026563)
License valid from 2017-04-07